Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy

Overview of attention for article published in Drug Design, Development and Therapy, July 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Wikipedia Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Antivirales de acción directa contra la hepatitis C: revisión narrativa

Article in Hepatología (May 2024)

Phase 1 study of safety and tolerability of an oral contraceptive containing low‐dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal women

Article in Journal of Viral Hepatitis (April 2024)

Virtual Screening of Telaprevir and Danoprevir Derivatives for Hepatitis C Virus NS3/4A Protease Inhibitors

Article in Letters in Drug Design & Discovery (January 2024)